Status:

COMPLETED

Lung Health Study II

Lead Sponsor:

University of Minnesota

Collaborating Sponsors:

National Heart, Lung, and Blood Institute (NHLBI)

Conditions:

Lung Diseases

Lung Diseases, Obstructive

Eligibility:

All Genders

40-69 years

Phase:

PHASE3

Brief Summary

To determine if participants with chronic obstructive pulmonary disease, who were assigned to inhaled corticosteroids had a lower rate of decline in lung function and lower incidence of respiratory mo...

Detailed Description

BACKGROUND: Chronic obstructive pulmonary disease (COPD), the fourth leading cause of death in the United States and a major cause of morbidity, is a spectrum of chronic lung diseases including clini...

Eligibility Criteria

Inclusion:

  1. Previously participated in or screened for the Lung Health Study I
  2. Ages 40 to 69
  3. Forced expiratory volume at one second (FEV1)/forced vital capacity(FVC) < 70 percent
  4. Forced expiratory volume at one second (FEV1) 30 to 90 percent predicted.

Exclusions:

  1. Cancer
  2. Recent myocardial infarction
  3. Alcoholism
  4. Heart Failure
  5. Insulin-dependent diabetes mellitus
  6. Neuropsychiatric disorders
  7. Used bronchodilators or oral or inhaled corticosteroids in previous year

Key Trial Info

Start Date :

September 1 1993

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 1999

Estimated Enrollment :

1116 Patients enrolled

Trial Details

Trial ID

NCT00000569

Start Date

September 1 1993

End Date

May 1 1999

Last Update

November 1 2019

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Lung Health Study II | DecenTrialz